Understanding WT1 Alterations and Expression Profiles in Hematological Malignancies

SIMPLE SUMMARY: The transcription factor Wilms tumor one (WT1) is highly expressed in malignant cells of patients with hematological malignancies, with a considerable percentage of patients harboring deactivating mutations in this gene. To date, the extent of WT1’s contribution to leukemogenesis is...

Descripción completa

Detalles Bibliográficos
Autores principales: Niktoreh, Naghmeh, Weber, Lisa, Walter, Christiane, Karimifard, Mahshad, Hoffmeister, Lina Marie, Breiter, Hannah, Thivakaran, Aniththa, Soldierer, Maren, Drexler, Hans Günther, Schaal, Heiner, Sendker, Stephanie, Reinhardt, Dirk, Schneider, Markus, Hanenberg, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340278/
https://www.ncbi.nlm.nih.gov/pubmed/37444601
http://dx.doi.org/10.3390/cancers15133491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340278/
https://www.ncbi.nlm.nih.gov/pubmed/37444601
http://dx.doi.org/10.3390/cancers15133491

Ejemplares similares